|  Help  |  About  |  Contact Us

Comment :

Type  MGI:General Description  treatment with SL327, an inhibitor of ERK, and rostafuroxin, a compound that selectively displaces ouabain from the Na+,K+-ATPase reduces the behavioral abnormalities of mutants